Sustained Remission in an Elderly Patient with Acute Myeloid Leukemia Following Gilteritinib Treatment as Third-Line Salvage Therapy Long-lasting disease remission with third line therapy with gilteritinib

Main Article Content

matteo molica
a:1:{s:5:"en_US";s:104:"Department of Hematology-Oncology, Azienda Universitaria Ospedaliera Renato Dulbecco, Catanzaro, Italy. ";}

Keywords

Abstract

Limited data are available on the effectiveness of gilteritinib as a third-line salvage therapy in patients with acute myeloid leukemia (AML). We present an elderly patient who achieved sustained remission following gilteritinib monotherapy as a third-line treatment after failing two prior regimens. 

Downloads

Download data is not yet available.


Abstract 0
PDF Downloads 0
HTML Downloads 0

Article Sidebar

PDF HTML
Published
Oct 31, 2024
DOI https://doi.org/10.4084/MJHID.2024.079

Article Details

How to Cite

molica, matteo (2024) “Sustained Remission in an Elderly Patient with Acute Myeloid Leukemia Following Gilteritinib Treatment as Third-Line Salvage Therapy: Long-lasting disease remission with third line therapy with gilteritinib”, Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024079. doi: 10.4084/MJHID.2024.079.
Issue
Vol. 16 No. 1 (2024): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Section
Letters to the Editor
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.